Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CORC
Cornwall Resources
$0.00
$0.00
$0.00
N/A-24.9211 shsN/A
MYMX
Mymetics
$0.01
$0.01
$0.01
$70.00
$2K1.646 shsN/A
NTII
Neurobiological Technologies
$0.00
$0.00
$0.00
N/A14.2N/AN/A
PANC
Panacos Pharmaceuticals
$0.00
$0.01
$0.01
N/A10.2418 shsN/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CORC
Cornwall Resources
0.00%0.00%0.00%0.00%-98.00%
MYMX
Mymetics
0.00%0.00%0.00%-96.16%+13.64%
NTII
Neurobiological Technologies
0.00%0.00%0.00%0.00%0.00%
PANC
Panacos Pharmaceuticals
0.00%0.00%0.00%+8,400.00%+8,400.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CORC
Cornwall Resources
N/AN/AN/AN/AN/AN/AN/AN/A
MYMX
Mymetics
N/AN/AN/AN/AN/AN/AN/AN/A
NTII
Neurobiological Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
PANC
Panacos Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CORC
Cornwall Resources
N/AN/AN/AN/A
MYMX
Mymetics
N/AN/AN/AN/A
NTII
Neurobiological Technologies
N/AN/AN/AN/A
PANC
Panacos Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CORC
Cornwall Resources
N/AN/AN/AN/AN/AN/A
MYMX
Mymetics
$1.08M0.00N/AN/A($0.23) per share-0.04
NTII
Neurobiological Technologies
N/AN/AN/AN/AN/AN/A
PANC
Panacos Pharmaceuticals
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CORC
Cornwall Resources
N/AN/A0.00N/AN/AN/AN/AN/AN/A
MYMX
Mymetics
-$5.06M-$0.04N/AN/A-1,914.40%N/A-128.84%N/A
NTII
Neurobiological Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
PANC
Panacos Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CORC
Cornwall Resources
N/AN/AN/AN/AN/A
MYMX
Mymetics
N/AN/AN/AN/AN/A
NTII
Neurobiological Technologies
N/AN/AN/AN/AN/A
PANC
Panacos Pharmaceuticals
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CORC
Cornwall Resources
N/A
MYMX
Mymetics
0.73%
NTII
Neurobiological Technologies
N/A
PANC
Panacos Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
CORC
Cornwall Resources
18.40%
MYMX
Mymetics
5.13%
NTII
Neurobiological Technologies
3.50%
PANC
Panacos Pharmaceuticals
6.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CORC
Cornwall Resources
17N/AN/ANot Optionable
MYMX
Mymetics
2150,000144,000Not Optionable
NTII
Neurobiological Technologies
4N/AN/ANot Optionable
PANC
Panacos Pharmaceuticals
41N/AN/ANot Optionable

PANC, CORC, MYMX, and NTII Headlines

No headlines for this company have been tracked by MarketBeat.com

Company Descriptions

Cornwall Resources

OTCMKTS:CORC
Cornwall Resources Corp., an independent oil and gas company, acquires and develops oil and gas properties located in Texas and Louisiana Gulf Coast. Cornwall Resources Corp. was formerly known as Columbia Energy Corp. and changed its name to Cornwall Resources Corp. in April 2012. The company was founded in 2006 and is based in Houston, Texas.

Mymetics

OTCMKTS:MYMX
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Neurobiological Technologies

OTCMKTS:NTII
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

Panacos Pharmaceuticals

OTCMKTS:PANC
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.